Advanced Search
Submit Manuscript Volume 33, No 8, Aug 2023
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 33 Issue 8, August 2023: 628-639 |
A novel N6-Deoxyadenine methyltransferase METL-9 modulates C. elegans immunity via dichotomous mechanisms
Chengchuan Ma1,2,3,4,†,* , Tingling Xue1,2,† , Qi Peng5,† , Jie Zhang5 , Jialiang Guan1,6 , Wanqiu Ding5 , Yi Li1,2 , Peixue Xia1,2 , Liankui Zhou1,2 , Tianyu Zhao1 , Sheng Wang7 , Li Quan1 , Chuan-Yun Li5,* , Ying Liu1,2,3,*
1State Key Laboratory of Membrane Biology, New Cornerstone Science Laboratory, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, ChinaN6-Methyldeoxyadenine (6mA) has been rediscovered as a DNA modification with potential biological function in metazoans. However, the physiological function and regulatory mechanisms regarding the establishment, maintenance and removal of 6mA in eukaryotes are still poorly understood. Here we show that genomic 6mA levels change in response to pathogenic infection in Caenorhabditis elegans (C. elegans). We further identify METL-9 as the methyltransferase that catalyzes DNA 6mA modifications upon pathogen infection. Deficiency of METL-9 impairs the induction of innate immune response genes and renders the animals more susceptible to pathogen infection. Interestingly, METL-9 functions through both 6mA-dependent and -independent mechanisms to transcriptionally regulate innate immunity. Our findings reveal that 6mA is a functional DNA modification in immunomodulation in C. elegans.
https://doi.org/10.1038/s41422-023-00826-y